Initial Combination With Pioglitazone Study (0431-064)

• Status: Completed
• Trial end date: 2008-06-28
• Target enrollment: 0
• Participant gender: All

Summary

A clinical study to evaluate the safety and efficacy of the initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes mellitus not on treatment with insulin or oral antihyperglycemic therapy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Pioglitazone; Sitagliptin Phosphate

Criteria

General Inclusion Criteria:

• Patients ≥18 years old with Type 2 Diabetes Mellitus (a specific type of diabetes)

General Exclusion Criteria:

• Patient has a history of type 1 diabetes mellitus or history of ketoacidosis

• Patient was on antihyperglycemic agent therapy (oral or insulin) within the prior 4 months

• Patient was on >4 weeks (cumulatively) of antihyperglycemic therapy (oral or insulin) over the prior 2 years